Results 111 to 120 of about 109,603 (331)

Obesity, White Adipose Tissue, and Adipokines Signaling in Male Reproduction

Molecular Nutrition &Food Research, EarlyView.
Role of adipokines in the hypothalamic‐pituitary‐gonadal axis (HPG) during obesity. Obesity induces structural and functional changes in WAT, with a consequent imbalance in the production and secretion of adipokines. While the adipokines adiponectin and omentin‐1 are downregulated, the adipokines leptin, resistin, vifastin, apelin, and chemerin are ...
Fabiane Ferreira Martins, Maria do Socorro Medeiros Amarante, Daiana Santana Oliveira, Isabela Macedo Lopes Vasques‐Monteiro, Vanessa Souza‐Mello, Julio Beltrame Daleprane, Christina da Silva Camillo   +6 more
wiley   +1 more source

Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors.

Journal of Lipid Research, 1996
The clinical relevance of apoE concentration in lipoprotein fractions should be evaluated. We investigated the impact of the common apolipoprotein (apo) E polymorphism in conjunction with very low density lipoprotein (VLDL) apoE concentration on the ...
K Bohnet, T Pillot, S Visvikis, N Sabolovic, G Siest   +4 more
doaj  

VLDL Hydrolysis by Hepatic Lipase Regulates PPARδ Transcriptional Responses

PLoS ONE, 2011
Background PPARs (α,γ,δ) are a family of ligand-activated transcription factors that regulate energy balance, including lipid metabolism. Despite these critical functions, the integration between specific pathways of lipid metabolism and distinct PPAR ...
Jonathan D. Brown, Eric J. Oligino, D. Rader, A. Saghatelian, J. Plutzky   +4 more
semanticscholar   +1 more source

Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apoprotein CIII [PDF]

, 2003
Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apoprotein CIII.BackgroundRecent studies have suggested that apoprotein (apo) CI in very low-density lipoprotein (VLDL) plays an important role in causing ...
Adachi, Mitsuru, Hirano, Tsutomu, Misaki, Asako, Murayama, Satoru, Okada, Kenta, Sakaue, Taro, Takahashi, Toshihiro, Takeuchi, Hiroko, Yoshino, Gen   +8 more
core   +1 more source

Yerba Mate (Ilex paraguariensis St. Hill.) Tea May Have Cardiometabolic Beneficial Effects in Healthy and At‐Risk Subjects: A Randomized, Controlled, Blind, Crossover Trial in Nonhabitual Consumers

Molecular Nutrition &Food Research, EarlyView.
Yerba mate intake shows cardiometabolic beneficial effects decreasing blood pressure, blood lipids, inflammatory biomarkers and body fat in healthy and hypercholesterolemic non‐habitual consumers. ABSTRACT Yerba mate has been reported to have antihypertensive, hypocholesterolemic, antidiabetic, or antiobesity properties.
Laura Bravo, Sara Martínez‐López, Jose Luis Sierra‐Cinos, Raquel Mateos, Beatriz Sarriá   +4 more
wiley   +1 more source

Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome

Journal of Lipid Research, 2012
We examined the effects of fenofibrate and atorvastatin on very low density lipoprotein (VLDL) apolipoprotein (apo)E metabolism in the metabolic syndrome (MetS). We studied 11 MetS men in a randomized, double-blind, crossover trial.
Esther M.M. Ooi, Theodore W.K. Ng, Gerald F. Watts, Dick C. Chan, P. Hugh R. Barrett   +4 more
doaj  

Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: results from the psychological, social and biological determinants of ill health (pSoBid) study [PDF]

, 2013
<p>Introduction: Cardio-metabolic risk factors have been associated with poor physical and mental health. Epidemiological studies have shown peripheral risk markers to be associated with poor cognitive functioning in normal healthy population and ...
Bender, Bornstein, Cardenas, Cavanagh, Dale, Danesh, de Jonge, Deans, Denke, Dietrich, Dowlati, Drake, Ehrlich, Elias, Elias, Fischl, Fischl, Fischl, Frank, Friston, Gallacher, Gruenewald, Gunstad, Habets, Hagler, Hannestad, Harrison, Helfand, Hoogendam, Huber, Isaac, Jefferson, Juster, Kin, Knox, Krauss, Krishnadas, Kuhn, Lekakis, Leritz, Linden, Liu, Liu, Lorenz, Luc, Marsland, McAfoose, McEwen, McGuinness, McLean, Miller, Nicholls, Noguchi, Packard, Palaniyappan, Panizzon, Phillips, Piras, Poldrack, Quinn, Raji, Rakic, Roeters van Lennep, Rosas, Schaberg, Schmidt, Seo, Seo, Shamai, Shiels, Smith, Solomon, Sowell, Stein, Taki, Teunissen, Toth, Umemura, van der Meer, Velupillai, Walther, Wannamethee, Ward, Wersching, Williams, Wright, Yaffe, Yokum   +87 more
core   +2 more sources

Proteome of Renal Tubuli and Serum Differentiate Pre‐Existing Type 2 Diabetes and Post‐Transplant Diabetes in Kidney Transplant Recipients

PROTEOMICS – Clinical Applications, EarlyView.
ABSTRACT Purpose Diabetes mellitus (DM) is a major cause of end‐stage kidney disease (ESKD), with kidney transplantation being the preferred treatment. However, post‐transplant diabetes mellitus (PTDM) increases mortality and graft loss. While PTDM and Type 2 diabetes mellitus (T2DM) share risk factors, their mechanisms differ, particularly in diabetic
Eleni Skandalou, Mariell Rivedal, Hans‐Peter Marti, Thea A. S. Halden, Trond Jenssen, Bjørn Egil Vikse, Anders Åsberg, Jessica Furriol   +7 more
wiley   +1 more source

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism

Journal of Lipid Research, 2008
Cholesteryl ester transfer protein (CETP) inhibition leads to changes in lipoprotein metabolism. We studied the effect of the CETP inhibitor torcetrapib on VLDL apolipoprotein E (apoE) metabolism.
John S. Millar, Margaret E. Brousseau, Margaret R. Diffenderfer, P. Hugh R. Barrett, Francine K. Welty, Jeffrey S. Cohn, Aisha Wilson, Megan L. Wolfe, Chorthip Nartsupha, Peter M. Schaefer, Andres G. Digenio, James P. Mancuso, Gregory G. Dolnikowski, Ernst J. Schaefer, Daniel J. Rader   +14 more
doaj  

Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice.

Journal of Clinical Investigation, 2010
Recent genome-wide association studies have identified a genetic locus at human chromosome 8q24 as having minor alleles associated with lower levels of plasma triglyceride (TG) and LDL cholesterol (LDL-C), higher levels of HDL-C, as well as decreased ...
R. Burkhardt, S. Toh, W. Lagor, A. Birkeland, Michael Levin, Xiaoyu Li, M. Robblee, V. D. Fedorov, Masahiro Yamamoto, T. Satoh, S. Akira, S. Kathiresan, J. Breslow, D. Rader   +13 more
semanticscholar   +1 more source